Publication | Closed Access

Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia

Metabolic SyndromePrimary HypercholesterolemiaCardiovascular DiseaseMedicineDiabetesHyperlipidemiaLipoprotein MetabolismApolipoprotein-specific High DensityPharmacologyAtherosclerosisDyslipidemia